Modulari-T Biosciences

Montreal, Canada

Modulari-T Biosciences develops novel antigen receptor architecture and cell therapies.

$500K raised

Apr 2023

Pre-Seed

Biotechnology Genetics Life Science

Top Investors

Y Combinator

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Modulari-T Biosciences

How much funding has Modulari-T Biosciences raised?

Modulari-T Biosciences has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.

Who are Modulari-T Biosciences's investors?

Modulari-T Biosciences's investors include Y Combinator.

Where is Modulari-T Biosciences headquartered?

Modulari-T Biosciences is headquartered in Montreal, Canada.

What does Modulari-T Biosciences do?

Modulari-T Biosciences develops novel antigen receptor architecture and cell therapies.

What stage is Modulari-T Biosciences at?

Modulari-T Biosciences is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 5, 2023.

MLA

"Modulari-T Biosciences — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/modulari-t-biosciences. Accessed June 17, 2026.

APA

VCBacked. (2023). Modulari-T Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/modulari-t-biosciences

Wikipedia (cite web)

{{cite web |title=Modulari-T Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/modulari-t-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 5, 2023.